Logo image of LMPX

LMP AUTOMOTIVE HOLDINGS INC (LMPX) Stock Fundamental Analysis

NASDAQ:LMPX - Nasdaq - US53952P1012 - Common Stock - Currency: USD

8.45  -0.3 (-3.43%)

After market: 8.45 0 (0%)

Fundamental Rating

1

Overall LMPX gets a fundamental rating of 1 out of 10. We evaluated LMPX against 122 industry peers in the Specialty Retail industry. Both the profitability and financial health of LMPX have multiple concerns. LMPX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

LMPX had positive earnings in the past year.
LMPX Yearly Net Income VS EBIT VS OCF VS FCFLMPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 -2M -4M -6M -8M -10M

1.2 Ratios

Industry RankSector Rank
ROA -8.43%
ROE N/A
ROIC 1.35%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LMPX Yearly ROA, ROE, ROICLMPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 -20 -40 -60

1.3 Margins

Industry RankSector Rank
OM 0.85%
PM (TTM) -5.14%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LMPX Yearly Profit, Operating, Gross MarginsLMPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 0 10 -10 -20 -30

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LMPX is destroying value.
The number of shares outstanding for LMPX has been increased compared to 1 year ago.
The debt/assets ratio for LMPX has been reduced compared to a year ago.
LMPX Yearly Shares OutstandingLMPX Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2M 4M 6M 8M 10M
LMPX Yearly Total Debt VS Total AssetsLMPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 10M 20M 30M

2.2 Solvency

LMPX has an Altman-Z score of 2.09. This is not the best score and indicates that LMPX is in the grey zone with still only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 2.24 is on the high side and indicates that LMPX has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 2.24
Debt/FCF N/A
Altman-Z 2.09
ROIC/WACC0.15
WACC9.11%
LMPX Yearly LT Debt VS Equity VS FCFLMPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 1.49 indicates that LMPX should not have too much problems paying its short term obligations.
LMPX has a Quick Ratio of 1.49. This is a bad value and indicates that LMPX is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 0.8
LMPX Yearly Current Assets VS Current LiabilitesLMPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 5M 10M 15M 20M 25M

3

3. Growth

3.1 Past

The earnings per share for LMPX have decreased strongly by -454.66% in the last year.
Looking at the last year, LMPX shows a very strong growth in Revenue. The Revenue has grown by 1092.76%.
LMPX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 100.80% yearly.
EPS 1Y (TTM)-454.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%711.94%
Revenue 1Y (TTM)1092.76%
Revenue growth 3Y100.8%
Revenue growth 5YN/A
Sales Q2Q%957.84%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-673.53%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year641.55%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LMPX Yearly Revenue VS EstimatesLMPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 100M 200M 300M 400M
LMPX Yearly EPS VS EstimatesLMPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 0 -0.5 -1 -1.5

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 6.65, the valuation of LMPX can be described as very cheap.
LMPX is valuated cheaply when we compare the Price/Earnings ratio to 27.25, which is the current average of the S&P500 Index.
LMPX is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 6.65
Fwd PE N/A
LMPX Price Earnings VS Forward Price EarningsLMPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 30.06
LMPX Per share dataLMPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

LMPX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LMP AUTOMOTIVE HOLDINGS INC

NASDAQ:LMPX (8/24/2022, 8:00:00 PM)

After market: 8.45 0 (0%)

8.45

-0.3 (-3.43%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)09-13 2022-09-13/amc
Inst Owners0.01%
Inst Owner Change0%
Ins Owners28.19%
Ins Owner Change0%
Market Cap92.18M
Analysts82.86
Price Target25.5 (201.78%)
Short Float %0.01%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.65
Fwd PE N/A
P/S 0.26
P/FCF N/A
P/OCF N/A
P/B 2.6
P/tB N/A
EV/EBITDA 30.06
EPS(TTM)1.27
EY15.03%
EPS(NY)-1.99
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS32.22
BVpS3.24
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.43%
ROE N/A
ROCE N/A
ROIC 1.35%
ROICexc N/A
ROICexgc 1.95%
OM 0.85%
PM (TTM) -5.14%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.64
Health
Industry RankSector Rank
Debt/Equity 2.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.49
Quick Ratio 0.8
Altman-Z 2.09
F-Score4
WACC9.11%
ROIC/WACC0.15
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-454.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%711.94%
EPS Next Y-673.53%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1092.76%
Revenue growth 3Y100.8%
Revenue growth 5YN/A
Sales Q2Q%957.84%
Revenue Next Year641.55%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A